-
ZEISS Medical Technology and Aier Eye Hospital Group Sign Strategic Agreement for 25 VISUMAX 800 Units
JENA, Germany, June 17, 2026 /PRNewswire/ — ZEISS Medical Technology announced today that the company held a signing ceremony with the Aier Eye Hospital Group, entering into a strategic agreement for the purchase and installation of 25 ZEISS VISUMAX 800 femtosecond lasers across multiple Aier Eye Hospital locations. The signing ceremony was conducted on June…
-
Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
The combination of selinexor plus ruxolitinib met the first co-primary endpoint demonstrating a statistically significant improvement of spleen volume reduction (SVR35) of 49.8% for the combination arm vs 28% for the control arm at week 24. Post-hoc analysis from the phase 3 SENTRY trial suggests SVR35 may predict overall survival (OS); new data from the…
-
IMG Shares 2026 Summer Travel Insights: Higher Spending and Longer Trips
IMG reviewed the travel itineraries of more than 30,000 of its members with upcoming travel plans between June 1st and August 31st of 2026 to determine notable travel trends this summer. INDIANAPOLIS, May 27, 2026 /PRNewswire/ — IMG (International Medical Group) has completed its annual review of summer travel data based on customer travel plans…
-
Her Bodhi Claims Evaluated: What Research Reveals About This Primal Queen Alternative, Weight Loss Support and Consumer Reviews
Editorial note: This article is an independent informational evaluation of publicly available product information. It is not medical advice, not a diagnosis or treatment recommendation, and not an endorsement of any brand. Dietary supplements are not medical devices and are not intended to diagnose, treat, cure, or prevent any disease, including menopause. Statements have not…
-
SMT Celebrates 20 Years of the Cocoon Occluder Journey, Transforming Lives in Congenital and Structural Heart Defects
Mumbai, Maharashtra, India Congenital Heart Disease (CHD) is one of the most common birth defects, affecting approximately 1% of live births globally and accounting for more than 4.18 million cases in children under five1. Despite advances in medical care, CHD continues to be a leading cause of infant and child mortality, highlighting the need for…
-
Noah Medical Appoints Dr. Krish Bhadra as Chief Pulmonary Advisor
Pioneering Physician and Interventional Pulmonology Innovator Joins Noah Medical to Accelerate the Next Era of Robotic-Assisted Lung Cancer Diagnosis and Treatment June 03, 2026 08:00 ET | Source: Noah Medical SAN CARLOS, Calif., June 03, 2026 (GLOBE NEWSWIRE) — Noah Medical, a medical robotics company dedicated to earlier, more accurate lung cancer diagnosis, announced the…
-
Morepen Labs Q4 Net Profit Rises 69 percent; CDMO Program Moves into Commercial Execution; Board Proposes a Dividend of 10 percent for FY 2025-26
Gurugram, Haryana, India Morepen Laboratories Limited reported strong Q4 FY26 performance with net profit rising 69% YoY to Rs. 20 crore and gross revenue increasing 22% YoY to Rs. 472 crore. Revenue growth during the quarter was supported by export momentum and expansion in the Medical Devices business, while operational momentum strengthened toward the latter…
-
Manipal Hospital EM Bypass Achieves a Significant Milestone in India’s Maternal Cardiac Care with Rare Twin Pregnancy Heart Procedure
KOLKATA, India, May 26, 2026 /PRNewswire/ — What began as a race against time to save a young mother struggling to breathe soon turned into a remarkable story of medical excellence and hope at Manipal Hospitals EM Bypass. In a rare and highly challenging intervention, Dr. Dilip Kumar, Director Cath Lab, Senior Interventional Cardiologist, Device and…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
